NO984524D0 - Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer - Google Patents
Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorerInfo
- Publication number
- NO984524D0 NO984524D0 NO984524A NO984524A NO984524D0 NO 984524 D0 NO984524 D0 NO 984524D0 NO 984524 A NO984524 A NO 984524A NO 984524 A NO984524 A NO 984524A NO 984524 D0 NO984524 D0 NO 984524D0
- Authority
- NO
- Norway
- Prior art keywords
- cholesterol
- uptake inhibitors
- amphipathic molecules
- lipid uptake
- lipid
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
- 235000012000 cholesterol Nutrition 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000002632 lipids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9606686.5A GB9606686D0 (en) | 1996-03-29 | 1996-03-29 | Medical use |
| GBGB9626920.4A GB9626920D0 (en) | 1996-12-24 | 1996-12-24 | Medical use |
| PCT/IB1997/000379 WO1997036927A1 (en) | 1996-03-29 | 1997-03-27 | Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO984524D0 true NO984524D0 (no) | 1998-09-28 |
| NO984524L NO984524L (no) | 1998-11-30 |
Family
ID=26309021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO984524A NO984524L (no) | 1996-03-29 | 1998-09-28 | Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20010005714A1 (no) |
| EP (1) | EP0889906A1 (no) |
| JP (1) | JP2000509020A (no) |
| CN (1) | CN1109047C (no) |
| AU (1) | AU710061B2 (no) |
| CA (1) | CA2249459A1 (no) |
| NO (1) | NO984524L (no) |
| NZ (1) | NZ331980A (no) |
| WO (1) | WO1997036927A1 (no) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037323A (en) * | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| US6004925A (en) | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| US6046166A (en) | 1997-09-29 | 2000-04-04 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| EP1090634A1 (en) * | 1999-10-01 | 2001-04-11 | Helmut Hauser | Agents for reducing cholesterol and lipid uptake |
| US7250304B2 (en) | 2000-03-31 | 2007-07-31 | The Regents Of The University Of California | Functional assay of high-density lipoprotein |
| US7148197B2 (en) * | 2000-08-24 | 2006-12-12 | The Regents Of The University Of California | Orally administered small peptides synergize statin activity |
| US7199102B2 (en) | 2000-08-24 | 2007-04-03 | The Regents Of The University Of California | Orally administered peptides synergize statin activity |
| US7166578B2 (en) | 2000-08-24 | 2007-01-23 | The Regents Of The University Of California | Orally administered peptides synergize statin activity |
| AU2007237157B2 (en) * | 2000-08-24 | 2009-04-09 | The Regents Of The University Of California | Peptides that ameliorate atherosclerosis |
| US6664230B1 (en) * | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| US7723303B2 (en) * | 2000-08-24 | 2010-05-25 | The Regents Of The University Of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
| US7144862B2 (en) | 2000-08-24 | 2006-12-05 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| CN100594933C (zh) * | 2000-11-28 | 2010-03-24 | 田边三菱制药株式会社 | 抗肥胖剂和健康食品 |
| US6930085B2 (en) | 2002-04-05 | 2005-08-16 | The Regents Of The University Of California | G-type peptides to ameliorate atherosclerosis |
| US20040067873A1 (en) | 2002-05-17 | 2004-04-08 | Dasseux Jean-Louis H. | Method of treating dyslipidemic disorders |
| CA2514303C (en) * | 2002-11-13 | 2012-09-18 | The Uab Research Foundation | Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use |
| DE10343815A1 (de) * | 2003-09-22 | 2005-04-14 | B.R.A.H.M.S Ag | Verfahren zur Diagnose von Erkrankungen unter Bestimmung von Apolipoprotein C-I, und dessen Verwendung in der Therapie von Erkrankungen |
| US20060205669A1 (en) * | 2004-09-16 | 2006-09-14 | The Regents Of The University Of California | G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| NZ555826A (en) | 2004-12-06 | 2009-11-27 | Univ California | Methods for improving the structure and function of arterioles |
| BRPI0610983A2 (pt) | 2005-04-29 | 2010-08-10 | Universirty Of California | peptìdeos e miméticos de peptìdeos para tratar patologias caracterizadas por uma resposta inflamatória |
| US20080293639A1 (en) * | 2005-04-29 | 2008-11-27 | The Regents Of The University Of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
| WO2007000924A1 (ja) * | 2005-06-28 | 2007-01-04 | Osaka University | プログラニュリン活性を抑制または促進する物質を含む医薬組成物、およびプログラニュリン活性を抑制または促進する物質のスクリーニング方法 |
| WO2007110296A1 (en) * | 2006-03-24 | 2007-10-04 | Unilever N.V. | Healthy food product |
| AU2007229604A1 (en) * | 2006-03-24 | 2007-10-04 | Unilever Plc | Healthy food product |
| EP1836906B1 (en) * | 2006-03-24 | 2009-07-01 | Unilever N.V. | Healthy food product |
| WO2008021088A2 (en) | 2006-08-08 | 2008-02-21 | The Regents Of The University Of Californina | Salicylanilides enhance oral delivery of therapeutic peptides |
| US9422363B2 (en) | 2007-08-28 | 2016-08-23 | Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| WO2009032702A2 (en) | 2007-08-28 | 2009-03-12 | Uab Research Foundation | Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| US9173890B2 (en) | 2007-09-20 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
| US8044021B2 (en) | 2007-09-20 | 2011-10-25 | Abbott Cardiovascular Systems Inc. | Sustained release of apo A-I mimetic peptides and methods of treatment |
| US7985727B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Apo A-I mimetic peptides and methods of treatment |
| US7985728B1 (en) | 2007-09-20 | 2011-07-26 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
| US8101565B2 (en) | 2007-09-20 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Sustained release of Apo A-I mimetic peptides and methods of treatment |
| USRE50320E1 (en) | 2014-07-31 | 2025-03-04 | Uab Research Foundation | APOE mimetic peptides and higher potency to clear plasma cholesterol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7797594A (en) * | 1993-09-15 | 1995-04-03 | Cv Therapeutics, Inc. | Protein for mediating cholesterol absorption and an inhibitor thereof |
| US5373009A (en) * | 1994-02-02 | 1994-12-13 | American Home Products Corporation | Dibenzofuranyl esters of N-heterocyclic carboxylic acids |
-
1997
- 1997-03-27 NZ NZ331980A patent/NZ331980A/xx unknown
- 1997-03-27 EP EP97914509A patent/EP0889906A1/en not_active Withdrawn
- 1997-03-27 CN CN97194265A patent/CN1109047C/zh not_active Expired - Fee Related
- 1997-03-27 CA CA002249459A patent/CA2249459A1/en not_active Abandoned
- 1997-03-27 JP JP9535088A patent/JP2000509020A/ja active Pending
- 1997-03-27 AU AU21741/97A patent/AU710061B2/en not_active Ceased
- 1997-03-27 WO PCT/IB1997/000379 patent/WO1997036927A1/en not_active Ceased
-
1998
- 1998-09-28 NO NO984524A patent/NO984524L/no not_active Application Discontinuation
- 1998-09-28 US US09/162,095 patent/US20010005714A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU710061B2 (en) | 1999-09-09 |
| AU2174197A (en) | 1997-10-22 |
| CN1109047C (zh) | 2003-05-21 |
| NO984524L (no) | 1998-11-30 |
| NZ331980A (en) | 2000-09-29 |
| US20010005714A1 (en) | 2001-06-28 |
| CN1216995A (zh) | 1999-05-19 |
| JP2000509020A (ja) | 2000-07-18 |
| WO1997036927A1 (en) | 1997-10-09 |
| EP0889906A1 (en) | 1999-01-13 |
| CA2249459A1 (en) | 1997-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO984524D0 (no) | Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer | |
| DK0900225T3 (da) | Alkyl-4-silyl-phenoler og estere deraf som antiatherosklerosemidler | |
| DK0818448T3 (da) | Cycloalkanopyridiner som CETP-inhibitorer | |
| DE69738510D1 (de) | Plasmaanzeigeeinrichtung in Unterrahmenmodus | |
| DK0925303T3 (da) | Phosphinsyreamider som matrixmetalloproteaseinhibitorer | |
| DK0944590T3 (da) | Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer | |
| DE69720878D1 (de) | Plasmaanzeigevorrichtung | |
| DK1037880T3 (da) | Anilider som retinsyremimetika | |
| AU5523098A (en) | Arylsulfonamides as phospholipase a2 inhibitors | |
| NO992725L (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
| DK0934259T3 (da) | Beta-sulfonamidohydroxamsyrer som matrixmetalloproteinase- og TACE-inhibitorer | |
| PT956294E (pt) | Inibidores da trombina | |
| DK0934264T3 (da) | Pyrrolidinyl- og pyrrolinylethylaminforbindelser som kappa-agonister | |
| FI982291A0 (fi) | Aine kolesterolin sekä lipidien pitoisuuden alentamiseksi | |
| NO991770L (no) | Bµrere som inneholder et eterlipid/komplementµr formlipidkombinasjon og terapeutisk bruk derav | |
| PT1051172E (pt) | Metodo para tratamento da dpco | |
| FI943441L (fi) | Tris-karbamiinihapon estereitä: kolesterolin absorption ehkäisyaineita | |
| BR9507992A (pt) | Esteres do ácido 4-carbamoilóxi-piperdino-1-carboxílico inibidores da absorção de colesterol | |
| KR950024444U (ko) | 판촉용 티슈 팩 | |
| KR970000223A (ko) | 콜레스테롤 생합성 저해제 | |
| BR9404556A (pt) | Expositor para aplicaçao geral | |
| BR7400858U (pt) | Expositor para brincos | |
| KR970056752U (ko) | 광고용 쇼케이스 | |
| BR7400219U (pt) | Painel original para exposição de medalhas | |
| ES1033026Y (es) | Expositor para calcetines. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |